Donato; Nicholas J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Donato; Nicholas J..The latest application filed is for "deubiquitinase inhibitors and methods for use of the same".

Company Profile

0.9.12

Donato; Nicholas J. - Ann Arbor MI
Donato; Nicholas J - Sugar Land TX
Donato; Nicholas J. - Sugar Land TX
Donato; Nicholas J. - Sugarland TX
Donato; Nicholas J. - Houston TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Deubiquitinase inhibitors and methods for use of the same Grant 9,868,736 - Donato , et al. January 16, 2	2018-01-16
Deubiquitinase Inhibitors And Methods For Use Of The Same App 20160237082 - Donato; Nicholas J. ; et al.	2016-08-18
Deubiquitinase Inhibitors and Methods for Use of the Same App 20140357673 - Donato; Nicholas J. ; et al.	2014-12-04
Deubiquitinase inhibitors and methods for use of the same Grant 8,809,377 - Donato , et al. August 19, 2	2014-08-19
Biomarker Identifying the Reactivation of STAT3 After Src Inhibition App 20130012519 - Johnson; Faye M. ; et al.	2013-01-10
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Grant 8,268,837 - Donato , et al. September 18, 2	2012-09-18
Deubiquitinase Inhibitors and Methods for Use of the Same App 20120077806 - Donato; Nicholas J. ; et al.	2012-03-29
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia Grant 8,119,649 - Donato , et al. February 21, 2	2012-02-21
Tryphostin-analogs For The Treatment Of Cell Proliferative Diseases App 20100292229 - Donato; Nicholas J ; et al.	2010-11-18
Biomaker Identifying The Reactivation Of Stat3 After Src Inhibition App 20100173426 - Johnson; Faye M. ; et al.	2010-07-08
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20090227608 - Donato; Nicholas J. ; et al.	2009-09-10
Use Of C-src Inhibitors Alone Or In Combination With Sti571 For The Treatment Of Leukaemia App 20070149539 - Donato; Nicholas J. ; et al.	2007-06-28
Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia App 20070027167 - Donato; Nicholas J. ; et al.	2007-02-01
Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia App 20060074094 - Donato; Nicholas J. ; et al.	2006-04-06
Process of isolating extract from the Euphorbia obesa plant and methods for using the same Grant 6,923,993 - Donato , et al. August 2, 2	2005-08-02
Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemia App 20040248906 - Donato, Nicholas J ; et al.	2004-12-09
Method of isolating extract from the euphorbaciae obesa plant and methods for using the same App 20030118677 - Donato, Nicholas D. ; et al.	2003-06-26
Anti-IgM monoclonal antibodies and methods of their use Grant 6,306,626 - Rosenblum , et al. October 23, 2	2001-10-23
Avidin-biotin immunoconjugates Grant 6,214,974 - Rosenblum , et al. April 10, 2	2001-04-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.